NuProbe
PrivateLast Round
Series B
Jun 2, 2022
Total Funding Raised
$61M
Company Overview
NuProbe is a biotechnology company that develops ultrasensitive genomics and molecular diagnostic technologies for the early detection of cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NuProbe Comparables
Compare NuProbe with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genecast | 77% | |
| Sysmex Corporation | 74% | |
| NeoGenomics Inc | 73% |
NuProbe Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 2, 2022 | ||||
| VC Round | Jan 11, 2021 | ||||
| Series A | Apr 23, 2018 |
NuProbe Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series B, VC Round |
| A. M. Pappas & Associates | Series B |
| Shanghai Deguan Asset Management | VC Round |
| CEC Capital Group | VC Round |
| Sequoia Capital | Series B, Series A |
| Yonghua Capital | Series B, VC Round |
| Serica Partners | VC Round, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2018
$11M round led by Sequoia Capital and Serica Partners
NuProbe Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NuProbe's valuation, stock price, and market status.
Is NuProbe a public or private company?
NuProbe is a private company.
What is the current stock price of NuProbe?
NuProbe is a private company with no public stock price. No recent secondary market data is available.
How much is NuProbe worth (valuation)?
Valuation information for NuProbe is not publicly available.
Can I buy NuProbe stock?
NuProbe shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NuProbe's last funding round?
NuProbe's most recent funding round was Series C on June 2, 2022.
Who are the main investors in NuProbe?
Key investors in NuProbe include BioTrack Capital, Sequoia Capital, Yonghua Capital, Serica Partners, Panlin Capital.
Will NuProbe IPO soon?
No public IPO plans have been announced for NuProbe.
How can I track NuProbe secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NuProbe's secondary market activity and sign up for updates.